UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.212

Sortiert nach

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Blood, 2020-03, Vol.135 (11), p.791-803

2020

Link zum Volltext

Verfügbarkeit prüfen

Integration of hypoxic HIF-α signaling in blood cancers

Oncogene, 2017-09, Vol.36 (38), p.5331-5340

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

Leukemia, 2016-02, Vol.30 (2), p.268-273

2016

Link zum Volltext

Verfügbarkeit prüfen

HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML

Leukemia, 2013-06, Vol.27 (6), p.1358-1368

2013

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway

Leukemia, 2008-04, Vol.22 (4), p.808-818

2008

Link zum Volltext

Verfügbarkeit prüfen

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

Leukemia, 2018-01, Vol.32 (1), p.241-244

2018

Link zum Volltext

Verfügbarkeit prüfen

The dual PI3 kinase mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML

Leukemia, 2008-09, Vol.22 (9), p.1728-1736

2008

Link zum Volltext

Verfügbarkeit prüfen

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

Leukemia, 2014-07, Vol.28 (7), p.1543-1545

2014

Link zum Volltext

Verfügbarkeit prüfen

Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn CXCR4 interactions in lipid rafts

Leukemia, 2012-05, Vol.26 (5), p.883-892

2012

Link zum Volltext

Verfügbarkeit prüfen

MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex

Leukemia, 2012-04, Vol.26 (4), p.778-787

2012

Link zum Volltext

Verfügbarkeit prüfen

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins

Leukemia, 2002-09, Vol.16 (9), p.1713-1724

2002

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis effector mechanisms: a requiem performed in different keys

Apoptosis (London), 2006-06, Vol.11 (6), p.889-904

2006

Link zum Volltext

Verfügbarkeit prüfen

Influence of IDH on FLT3-ITD status in newly diagnosed AML

Leukemia, 2017-11, Vol.31 (11), p.2526-2529

2017

Link zum Volltext

Verfügbarkeit prüfen

Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients

Leukemia, 2011-11, Vol.25 (11), p.1711-1717

2011

Link zum Volltext

Verfügbarkeit prüfen

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Leukemia, 2014-04, Vol.28 (4), p.973-975

2014

Link zum Volltext

Verfügbarkeit prüfen

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

Leukemia, 2017-02, Vol.31 (2), p.318-324

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia

Leukemia, 2005-09, Vol.19 (9), p.1543-1549

2005

Link zum Volltext

Verfügbarkeit prüfen

A STAT3 DEGRADER DEMONSTRATES PRE-CLINICAL EFFICACY IN VENETOCLAX RESISTANT MDS & AML

Leukemia research reports, 2024, Vol.21, p.100445

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification by enzyme immunoassay of escape mutants S143L and G145R of hepatitis B virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus)

Voprosy virusologiĭ, 2022-03, Vol.67 (1), p.48-58

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

Leukemia, 2004-02, Vol.18 (2), p.267-275

2004

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

The Journal of clinical investigation, 2001-09, Vol.108 (6), p.851-859

2001

Link zum Volltext

Verfügbarkeit prüfen

ANTIVIRAL EFFECT OF «KAGOCEL» SUBSTANCE IN VITRO ON INFLUENZA VIRUSES H1N1, H1N1PDM09 AND H3N2

Voprosy virusologiĭ, 2019-01, Vol.64 (3), p.125-131

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

Blood cancer journal (New York), 2017-03, Vol.7 (3), p.e542-e542

2017

Link zum Volltext

Verfügbarkeit prüfen

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.939-946

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.174)
Mit Volltextzugriff
(1.140)

Publikationsform

Sprache

Englisch
(1.171)
Japanisch
(75)
Russisch
(48)

Erscheinungsjahr

n.n

Thema

Science & Technology
(384)
Life Sciences & Biomedicine
(324)
Humans
(284)
Hematology
(191)
Oncology
(166)
Female
(130)
Male
(127)
Leukemia
(124)
Aged
(118)
Middle Aged
(118)
Adult
(110)
Leukemia, Myeloid, Acute - Drug Therapy
(99)
Acute Myeloid Leukemia
(86)
Animals
(70)
Aged, 80 And Over
(67)
Mutation
(64)
Leukemia, Myeloid, Acute - Genetics
(63)
Young Adult
(56)
Treatment Outcome
(54)
Chemotherapy
(53)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(506)
Journal Of Clinical Oncology
(94)
Cancer
(50)
Leukemia
(39)
American Journal Of Hematology
(36)
Hemasphere
(28)
Clinical Lymphoma, Myeloma And Leukemia
(27)
Cancer Research
(22)
Blood Advances
(21)
Haematologica
(19)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Integration of hypoxic HIF-α signaling in blood cancers

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML

Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

The dual PI3 kinase mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn CXCR4 interactions in lipid rafts

MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Apoptosis effector mechanisms: a requiem performed in different keys

Influence of IDH on FLT3-ITD status in newly diagnosed AML

Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia

A STAT3 DEGRADER DEMONSTRATES PRE-CLINICAL EFFICACY IN VENETOCLAX RESISTANT MDS & AML

Identification by enzyme immunoassay of escape mutants S143L and G145R of hepatitis B virus (Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus)

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

ANTIVIRAL EFFECT OF «KAGOCEL» SUBSTANCE IN VITRO ON INFLUENZA VIRUSES H1N1, H1N1PDM09 AND H3N2

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

Suchergebnisse filtern